8.15am - 5.30pm EDT | 5.15am - 1.30pm PDT
8:30 am Chair’s Opening Remarks
8:40 am Industry Leaders’ Fireside Chat: The Future of TCR Therapies
Synopsis
• Current state of the field – various TCR approaches
• Future research and development themes
• Patient populations and delivery – taking T cell therapy mainstream
• Why autologous and allogeneic methods will co-exist
9:30 am The Road to Commercialization: Preparing for BLA, Commercial Readiness, Upscaling Manufacturing for the First Commercial TCR-T Cell Therapy
Synopsis
• Regulatory challenges for an autologous TCR-T cell therapy and companion diagnostics
• Creating a commercial infrastructure to enter a field where prescribers and payers have limited cell therapy experience in solid tumors
• Manufacturing challenges for a product ready for a franchise